Lv1
18 积分 2023-08-29 加入
Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models
2天前
已完结
Safe Redosable Low-Immunogenic In Vivo CAR-T Therapy for B Cell Malignancies and Solid Tumors
2天前
待确认
Localized PD-1 CAR T therapy reprograms neuroinflammation
2天前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
2天前
已完结
An atlas of transcribed enhancers across helper T cell diversity for decoding human diseases
1个月前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
1个月前
已完结
In vivo nano-engineering T cells for CAR-T therapy
2个月前
已完结
Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors
7个月前
已完结
广西南宁地区血清胃蛋白酶原参考区间的建立与验证
11个月前
已完结
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
1年前
已完结
皖公网安备34019202002308
